Advancing Psychedelic Therapies for Mental Health Treatment in the U.S.

America is grappling with significant mental health challenges. Daily, over 130 individuals, including more than 20 veterans, die by suicide. Innovative therapies involving psychedelics show potential as alternative treatments for conditions like treatment-resistant depression, PTSD, substance use disorders, and generalized anxiety disorder.

Psychedelic-assisted therapies are proving promising, yet many Americans pursue these treatments overseas. The Trump administration made strides with FDA designations for groundbreaking therapies using substances like psilocybin and MDMA. However, federal efforts must intensify to bring these therapies to those in need within the U.S.

Two years ago, the bipartisan Congressional Psychedelics Advancing Therapies (PATH) Caucus sought input on integrating psychedelic medicines into the national healthcare system safely and effectively. Feedback revealed that psychedelics can drastically aid in treatment if provided securely and under suitable conditions.

A national framework is necessary, establishing standards for the medical application of these therapies. Nationwide guidelines should ensure equitable and safe access, defining service delivery and practitioner credentialing. These policies are crucial as FDA approvals for psychedelic medicines approach.

Notably, labeling requirements, crisis response protocols, and sessions’ integration support are vital components. For psychedelic medicine to reach its full potential in public health, Congress and federal agencies must directly address these emerging issues.

The integration of psychedelic-assisted therapies into American healthcare is inevitable. The primary focus should be on safe and effective incorporation. Establishing standards that protect patients and ensure equitable access is essential for addressing severe mental and physical health challenges.

Jack Bergman, representing Michigan’s 1st Congressional District, is a retired Marine Corps lieutenant general. Lou Correa, representing California’s 46th Congressional District, serves as co-chair of the Congressional PATH Caucus.